Date published:
June 15, 2020

Lifecare’s partner Digital Diagnostics AG seeks additional approval in Germany for corona virus rapid test

Plan for scaling capacities with production partners in USA and Europe and aim to bring test to the market in millions.

The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has developed an accurate and reliable rapid test able to detect corona virus from the time of infection, contrary to other tests on the market that can only detect the antibodies 5-7 days after the infection. The test is independent of lab analysis, providing test result within minutes at the point-of-care.

Digital Diagnostics announced June 12th, 2020, that the company has applied to the German Federal Institute for Drugs and Medical Devices (BfArM) for approval of the Digid CantisenseTM SARS-CoV-2 test for Germany. This application comes in addition to the previous application to the US FDA, announced June 2de, 2020.

Digital Diagnostics expect approval from BfArM and FDA in the next few weeks, where after the goal is to bring the tests to the market in millions. In the short-term Digital Diagnostics are further scaling its capasities with production partners in the USA and Europe.  

https://app.handelsblatt.com/technik/forschung-medizin/pandemie-corona-nachweis-in-fuenf-minuten-neue-generation-von-schnelltests-draengt-auf-den-markt/25905060.html?ticket=ST-3806779-6C6zKjUKJhghdkEmaDdF-ap3

For additional background information, we refer to:

https://newsweb.oslobors.no/message/506937

Press contact Lifecare

Christian Saure

Chairman of the Board

christian@sternacap.no

+47 909 33 148

Other publications

Date published:
November 22, 2020

Lifecare AS enhances its board with diabetes-, technology- and M&A experience

Read more
Date published:
November 12, 2020

Lifecare presents scientific update at the annual Diabetes Technology Meeting

Read more
Date published:
November 10, 2020

Rune Frisvold has resigned as Lifecare COO and is no longer affiliated with the company.

Read more